Major regulatory actions, e.g., the U.S. EPA PTAP Data Call In and revisions to EU GMP Annex 1 – Manufacture of Sterile Medicinal Products illuminate a clear trend: Regulators are requiring pharmaceutical manufacturers to make significant changes to the products and processes used in cleanroom disinfection. This short eBook gives you a detailed outlook on what global regulatory changes mean today — and what they signal for the future. Get clear insights on how to build a forward-thinking cleanroom disinfection program and achieve key goals:
- Create a global, sustainable portfolio
- Streamline future global compliance
- Improve operational efficiency
- Protect cleanroom equipment